These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 21442127)
21. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells. Bai Y; Li Q; Yang J; Zhou X; Yin X; Zhao D Neurosci Res; 2008 Sep; 62(1):9-14. PubMed ID: 18602709 [TBL] [Abstract][Full Text] [Related]
22. Amidation and structure relaxation abolish the neurotoxicity of the prion peptide PrP106-126 in vivo and in vitro. Bergström AL; Cordes H; Zsurger N; Heegaard PM; Laursen H; Chabry J J Biol Chem; 2005 Jun; 280(24):23114-21. PubMed ID: 15824101 [TBL] [Abstract][Full Text] [Related]
23. Astrocytic regulation of NMDA receptor subunit composition modulates the toxicity of prion peptide PrP106-126. Sassoon J; Daniels M; Brown DR Mol Cell Neurosci; 2004 Jan; 25(1):181-91. PubMed ID: 14962751 [TBL] [Abstract][Full Text] [Related]
24. Oxidation reduces the fibrillation but not the neurotoxicity of the prion peptide PrP106-126. Bergström AL; Chabry J; Bastholm L; Heegaard PM Biochim Biophys Acta; 2007 Sep; 1774(9):1118-27. PubMed ID: 17707142 [TBL] [Abstract][Full Text] [Related]
25. Neurotoxicity of a prion protein fragment. Forloni G; Angeretti N; Chiesa R; Monzani E; Salmona M; Bugiani O; Tagliavini F Nature; 1993 Apr; 362(6420):543-6. PubMed ID: 8464494 [TBL] [Abstract][Full Text] [Related]
26. Prion peptide 106-126 as a model for prion replication and neurotoxicity. Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566 [TBL] [Abstract][Full Text] [Related]
27. PrPSc-like prion protein peptide inhibits the function of cellular prion protein. Brown DR Biochem J; 2000 Dec; 352 Pt 2(Pt 2):511-8. PubMed ID: 11085945 [TBL] [Abstract][Full Text] [Related]
29. Heteronuclear and homonuclear Cu2+ and Zn2+ complexes with multihistidine peptides based on zebrafish prion-like protein. Valensin D; Szyrwiel Ł; Camponeschi F; Rowińska-Zyrek M; Molteni E; Jankowska E; Szymanska A; Gaggelli E; Valensin G; Kozłowski H Inorg Chem; 2009 Aug; 48(15):7330-40. PubMed ID: 19586023 [TBL] [Abstract][Full Text] [Related]
30. Influence of divalent copper, manganese and zinc ions on fibril nucleation and elongation of the amyloid-like yeast prion determinant Sup35p-NM. Suhre MH; Hess S; Golser AV; Scheibel T J Inorg Biochem; 2009 Dec; 103(12):1711-20. PubMed ID: 19853305 [TBL] [Abstract][Full Text] [Related]
31. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity. Salmona M; Forloni G; Diomede L; Algeri M; De Gioia L; Angeretti N; Giaccone G; Tagliavini F; Bugiani O Neurobiol Dis; 1997; 4(1):47-57. PubMed ID: 9258911 [TBL] [Abstract][Full Text] [Related]
32. Palladium complexes affect the aggregation of human prion protein PrP106-126. Wang Y; Feng L; Zhang B; Wang X; Huang C; Li Y; Du W Inorg Chem; 2011 May; 50(10):4340-8. PubMed ID: 21504185 [TBL] [Abstract][Full Text] [Related]
33. Copper (II) promotes the formation of soluble neurotoxic PrP oligomers in acidic environment. Wu D; Zhang W; Luo Q; Luo K; Huang L; Wang W; Huang T; Chen R; Lin Y; Pang D; Xiao G J Cell Biochem; 2010 Oct; 111(3):627-33. PubMed ID: 20564047 [TBL] [Abstract][Full Text] [Related]
34. An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells. Kazlauskaite J; Young A; Gardner CE; Macpherson JV; Vénien-Bryan C; Pinheiro TJ Biochem Biophys Res Commun; 2005 Mar; 328(1):292-305. PubMed ID: 15670783 [TBL] [Abstract][Full Text] [Related]
35. A doppel alpha-helix peptide fragment mimics the copper(II) interactions with the whole protein. La Mendola D; Magrì A; Campagna T; Campitiello MA; Raiola L; Isernia C; Hansson O; Bonomo RP; Rizzarelli E Chemistry; 2010 Jun; 16(21):6212-23. PubMed ID: 20411530 [TBL] [Abstract][Full Text] [Related]
36. The role of hydrophobic interactions in amyloidogenesis: example of prion-related polypeptides. Tcherkasskaya O; Sanders W; Chynwat V; Davidson EA; Orser CS J Biomol Struct Dyn; 2003 Dec; 21(3):353-65. PubMed ID: 14616031 [TBL] [Abstract][Full Text] [Related]
37. The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126. Jobling MF; Stewart LR; White AR; McLean C; Friedhuber A; Maher F; Beyreuther K; Masters CL; Barrow CJ; Collins SJ; Cappai R J Neurochem; 1999 Oct; 73(4):1557-65. PubMed ID: 10501201 [TBL] [Abstract][Full Text] [Related]
38. Regulation of aggregation behavior and neurotoxicity of prion neuropeptides by platinum complexes. Wang X; Cui M; Zhao C; He L; Zhu D; Wang B; Du W Inorg Chem; 2014 May; 53(10):5044-54. PubMed ID: 24787240 [TBL] [Abstract][Full Text] [Related]
39. Cytotoxicity of prion protein peptide (PrP106-126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, A beta 25-35. Hope J; Shearman MS; Baxter HC; Chong A; Kelly SM; Price NC Neurodegeneration; 1996 Mar; 5(1):1-11. PubMed ID: 8731376 [TBL] [Abstract][Full Text] [Related]
40. Altered expression of the prion gene in rat astrocyte and neuron cultures treated with prion peptide 106-126. Ning ZY; Zhao DM; Liu HX; Yang JM; Han CX; Cui YL; Meng LP; Wu CD; Liu ML; Zhang TX Cell Mol Neurobiol; 2005 Dec; 25(8):1171-83. PubMed ID: 16388330 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]